Ziqin Wang | Toxicology and Pharmaceutical Science | Innovative Research Award

Published on by Invention Awards

Innovative Research Award

Ziqin Wang
Beijing Chaoyang Kaiwen Academy

Researcher Profile
Affiliation Beijing Chaoyang Kaiwen Academy
Country China
Subject Area Toxicology and Pharmaceutical Science
Event International Invention Awards
ORCID 0009-0004-2036-3316

Ziqin Wang is associated with Beijing Chaoyang Kaiwen Academy in China, with toxicology and pharmaceutical science identified as the relevant subject areas in the supplied profile. These disciplines investigate the biological effects of chemical substances, pharmaceutical safety, therapeutic development, and evidence-based approaches to evaluating medicines.methodological quality, and research relevance. Specific publications, research achievements, and bibliometric indicators require independent verification before attribution. Established toxicological assessment principles and pharmaceutical research guidance provide a foundation for evaluating scientific contributions in these fields.[1][2]

Abstract

This article presents an academic recognition profile for Ziqin Wang of Beijing Chaoyang Kaiwen Academy, China, in connection with the Innovative Research Award and the International Invention Awards. The stated subject areas are toxicology and pharmaceutical science, which encompass chemical safety, biological responses, therapeutic substances, and pharmaceutical development. The profile outlines relevant research themes and describes considerations for evaluating originality, methodological quality, scientific integrity, and practical relevance. Specific publications, research achievements, citation counts, and other bibliometric indicators have not been independently verified. Authoritative institutional records and scholarly databases should be consulted before attributing individual accomplishments or drawing conclusions about research impact or award eligibility.

Keywords

Ziqin Wang, Innovative Research Award, International Invention Awards, toxicology, pharmaceutical science, drug safety, pharmacological research, chemical risk assessment, pharmaceutical innovation, scientific research, biomedical development, research evaluation.

Introduction

Scientific innovation advances knowledge by introducing new methods, testing hypotheses, and addressing unresolved research questions. Toxicology and pharmaceutical science contribute to this process through investigations of chemical hazards, biological mechanisms, drug safety, and therapeutic development. Evaluating work in these areas requires attention to experimental design, reproducibility, ethical conduct, and the strength of supporting evidence. Internationally recognized scientific and pharmaceutical guidance provides useful context for understanding these requirements.[1][2]

Research Profile

The supplied information identifies Ziqin Wang with Beijing Chaoyang Kaiwen Academy in China and lists toxicology and pharmaceutical science as relevant subject areas. These fields combine concepts from chemistry, biology, pharmacology, and health sciences to examine the effects of substances and the development of therapeutic products. The available information does not independently establish a specific research appointment, degree, laboratory affiliation, or publication history. Additional details should be confirmed through institutional documentation, scholarly records, or the researcher’s verified public profile before inclusion in a formal academic biography.[3]

Research Contributions

Potential contributions within toxicology and pharmaceutical science include the assessment of chemical hazards, analysis of dose-response relationships, investigation of biological mechanisms, and development of improved methods for evaluating substance safety. Pharmaceutical research can also address formulation, drug delivery, analytical techniques, and the evaluation of therapeutic candidates. These examples describe the broader scientific disciplines and should not be interpreted as confirmed achievements by Ziqin Wang. Individual discoveries, inventions, experimental results, or original methods should be attributed only when supported by identifiable publications, patents, institutional records, or other reliable evidence.[1][2]

Publications

A verified publication record helps establish research activity, subject expertise, and scholarly contributions. Relevant materials may include peer-reviewed journal articles, conference papers, research reports, and publications describing original experimental findings. Each record should be checked for authorship, publication details, journal information, and a persistent identifier such as a digital object identifier (DOI), when available. No specific publication or DOI has been verified for this profile. Consequently, publication titles and numerical research indicators should be added only after checking appropriate scholarly databases and original publication records.[3]

Research Impact

Research impact can be examined through scientific quality, reproducibility, independent citation, practical application, and relevance to important research questions. In toxicology and pharmaceutical science, meaningful outcomes may include stronger safety assessment methods, improved understanding of biological effects, or evidence that supports further therapeutic development. Citation counts and h-index values can indicate aspects of scholarly visibility but cannot independently establish originality or practical benefit. An evidence-based assessment of Ziqin Wang’s research impact requires verified publications, documented research outputs, and independent evidence of how the work has contributed to scientific understanding or subsequent applications.[1]

Award Suitability

The Innovative Research Award provides a framework for recognizing work that may demonstrate originality, methodological rigor, scientific relevance, and responsible innovation. In toxicology and pharmaceutical science, a nomination may be supported by documented research findings, validated methods, relevant publications, patents, or evidence of practical application. The supplied profile information alone is insufficient to establish award eligibility or determine the strength of a nomination. A fair assessment should use the International Invention Awards’ applicable eligibility requirements and evaluation criteria, supported by reliable documentation and a transparent review process.[3]

Conclusion

This profile presents Ziqin Wang in the context of Beijing Chaoyang Kaiwen Academy, China, and the subject areas of toxicology and pharmaceutical science. It outlines the broader scientific context of the Innovative Research Award and the importance of originality, reproducibility, and evidence-based evaluation. A complete academic assessment requires verified scholarly outputs, documented research achievements, and confirmation of the relevant award criteria. The inclusion of numbered references links the discussion to sources on toxicological assessment, pharmaceutical guidance, and researcher identification, while maintaining a clear distinction between supplied profile information and independently established facts.

References

  1. ORCID. (n.d.). ORCID: Connecting Research and Researchers. ORCID.
    https://orcid.org/0009-0004-2036-3316
  2. Journal article. (2026. ) Cardiolipin-Specific Targeting of Melittin via Arg22 in Lipid Membranes: A Natural Toxin-Based Strategy for Treating Mitochondrial Dysfunction in Aging and Disease.
    https://doi.org/10.3390/toxins18100432
  3. International Invention Awards. (2026.). Official website.
    https://inventionawards.org/

Avijit Mazumder | Toxicology and Pharmaceutical Science | Best Academic Researcher Award

Published on by Invention Awards
After Completing the Registration Process, your Biography will be displayed here.

Register by using your Entry ID: 26246

Register Here

 

Lee Jia | Pharmacy | Research Excellence Award

Published on by Invention Awards

Prof. Lee Jia | Pharmacy | Research Excellence Award

Distinguished Professor and Director in Henan University, United States

Prof. Lee Jia is a highly accomplished pharmacologist with a strong academic foundation, earning his Ph.D. in Pharmacology from the State University of New York under Nobel Laureate Robert F. Furchgott and completing postdoctoral research at Duke University Medical Center in Durham, North Carolina. He currently serves as Distinguished Professor at The First Affiliated Hospital of Henan University and has held key leadership roles including Director of the Marine Drug R&D Center at Minjiang University and founding director of a cancer metastasis research center at Fuzhou University. His international career includes senior scientific positions at the National Cancer Institute, National Institutes of Health, and collaborations with institutions such as University of Geneva and Technological University Dublin. He is widely recognized for contributions to pharmacology, toxicology, nanomedicine, and cancer research, earning distinctions such as Fellow of the American Association of Pharmaceutical Scientists, Fellow of the Academy of Toxicological Sciences, and selection among the world’s top 2% scientists by Stanford University and Elsevier. He has received numerous prestigious honors including major national innovation awards in China, international research recognitions, and leadership roles in scientific societies such as the Chinese Pharmaceutical Association. In addition to his research impact, he has made extensive contributions as an editor, reviewer, and scientific organizer across leading journals and global conferences, shaping advancements in drug discovery and translational medicine.

Citation Metrics (Scopus)

15000
12000
9000
6000
3000
100
0

Citations
13224

Documents
226

h-index
55

Citations

Documents

h-index

View Scopus Profile

Featured Publications

 

Dr. Ambika Verma | Geriatrics | Best Researcher Award

Published on by Invention Awards

Dr. Ambika Verma | Geriatrics | Best Researcher Award

Dr. Ambika Verma | Geriatrics | Best Researcher Award

University of Arkansas for Medical Sciences, United States

Profile

google scholar

🎓 Early Academic Pursuits

Dr. Ambika Verma embarked on her academic journey with a Bachelor’s degree in Life Sciences from Punjab University, Chandigarh (2007–2010), where she laid a strong foundation in biology and allied sciences. She pursued her Master’s (2010–2013) and Ph.D. (2013–2016) in Biotechnology from Dr. Yashwant Singh Parmar University of Horticulture and Forestry, Solan, Himachal Pradesh, India. Her doctoral research, guided by Dr. Poonam Shirkot, focused on the production and purification of indigenous bacterial enzymes and their applications, leading to substantial publications and recognition through the Best Doctoral Thesis Award by SADHNA Society, India.

🧪 Professional Endeavors

Dr. Verma has accumulated over 9 years of post-doctoral research experience across reputed institutions in India and the United States. She held pivotal roles including Senior Research Fellow and National Post-doctoral Fellow at ICAR-Central Potato Research Institute (CPRI), Shimla, contributing significantly to plant protection and pathogen diagnostics. Her international career advanced at the University of Arkansas for Medical Sciences (UAMS), where she served as a Research Assistant (2019–2021) in Microbiology & Immunology and currently continues as a Post-doctoral Fellow (2021–present) in the Department of Geriatrics.

🔬 Contributions and Research Focus

Dr. Verma's interdisciplinary research spans plant protection, bacterial pathogenesis, and neuroinflammation in aging and dementia. Her current work under Dr. Jeanne Wei and Dr. Gohar Azhar at UAMS centers on P. gingivalis-LPS induced inflammasome activation in Alzheimer's Disease and related dementias (ADRD). Previously, under Dr. Youssef Aachoui, she explored canonical and non-canonical inflammasome pathways in response to bacterial infections. Her earlier work at ICAR-CPRI focused on diagnostic techniques against potato pathogens, blending molecular diagnostics with agricultural biotechnology.

📈 Impact and Influence

Dr. Verma has authored over 40 peer-reviewed publications, with impactful research disseminated across areas of immunology, gerontology, plant pathology, and biotechnology. Her work has been integral in understanding both host-pathogen interactions and neuroimmune mechanisms in aging, thereby contributing to two major domains of global health: food security and neurodegeneration. She has received numerous honors, including the Best Poster Award by GSA's ESPO (2023) and a Travel Award (2024) in biological sciences, affirming her growing influence in the field of gerontology.

📚 Academic Citations and Recognitions

Her scholarly impact is evidenced by multiple awards for best theses, project coordination roles in DST-funded initiatives, and national level recognition such as qualifying the ASRB National Eligibility Test (NET). She has also served as a judge at academic fairs and student research events, such as the UAMS Student Research Day (2025) and Little Rock Science & Humanities Fair (2020), further reflecting her dedication to academic service and outreach.

🧰 Technical Skills and Methodologies

Dr. Verma possesses a robust skill set that includes molecular cloning, PCR diagnostics, microbial cultivation, and inflammasome activation assays. She has proficiency in handling both plant and mammalian systems, bridging agricultural sciences with biomedical research. Her experimental expertise includes work on bacterial enzyme isolation, protein purification, LPS-based inflammation models, and advanced cellular assays for neuroinflammation and pathogen response.

🧑‍🏫 Teaching and Mentorship

With teaching experiences spanning from 2013 to the present, Dr. Verma has mentored students in both India and the U.S. She has contributed to academic instruction at Dr. YSP UHF, ICAR-CPRI, and UAMS, particularly in the Departments of Geriatrics and Microbiology & Immunology. Her mentorship has supported junior researchers, graduate students, and trainees, emphasizing scientific rigor, cross-disciplinary knowledge, and ethical research practices.

🌐 Leadership, Membership, and Service

Dr. Verma is a member of the Gerontological Society of America (2023–2025) and holds lifetime memberships with scientific societies such as SADHNA and the Association of Biotechnologists of HP. Her leadership roles include project coordination, peer mentoring, and participation in competitive grant-writing programs like Path 2K at UAMS. She has been a proactive participant in institutional and national scientific communities, demonstrating both administrative and collaborative leadership.

🔮 Legacy and Future Contributions

With a rare combination of plant biotechnology roots and gerontology-focused translational research, Dr. Verma is uniquely positioned to advance cross-disciplinary scientific inquiry. Her ongoing investigations into neuroimmune mechanisms in aging populations are expected to inform therapeutic strategies for Alzheimer’s Disease and related dementias. Through her dual expertise, she continues to inspire integrated solutions for health, agriculture, and molecular science, laying the foundation for impactful academic, clinical, and public health advancements.

📚 Selected Publications

  • Purification and characterization of thermostable laccase from thermophilic Geobacillus thermocatenulatus MS5 and its applications in removal of textile dyes
    Authors: A Verma, P Shirkot
    Journal: Sch Acad J Biosci 2 (8), 479-485
    Year: 2014

  • Neutrophil caspase-11 is essential to defend against a cytosol-invasive bacterium
    Authors: SB Kovacs, C Oh, VI Maltez, BD McGlaughon, A Verma, EA Miao, ...
    Journal: Cell Reports 32 (4)
    Year: 2020

  • Isolation and characterization of thermophilic bacteria in natural hot water springs of Himachal Pradesh (India)
    Authors: A Verma, M Gupta, P Shirkot
    Journal: The Bioscan 9 (3), 947-952
    Year: 2014

  • P. gingivalis-LPS Induces Mitochondrial Dysfunction Mediated by Neuroinflammation through Oxidative Stress
    Authors: A Verma, G Azhar, X Zhang, P Patyal, G Kc, S Sharma, Y Che, JY Wei
    Journal: International Journal of Molecular Sciences 24 (2), 950
    Year: 2023

  • Shigella OspC3 suppresses murine cytosolic LPS sensing
    Authors: C Oh, A Verma, M Hafeez, B Hogland, Y Aachoui
    Journal: IScience 24 (8)
    Year: 2021